Actively Recruiting
Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.
Led by Baskent University Ankara Hospital · Updated on 2024-11-01
1000
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
Sponsors
B
Baskent University Ankara Hospital
Lead Sponsor
H
Hacettepe University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study includes preterm infants who are being screened for ROP between August 1,2023 and August 1, 2024 in 94 neonatal intensive care units (NICUs) in Turkey. Infants with birth weight (BW) of \>1500 g or ≥ 33 weeks' gestation who are screened for retinopathy of prematurity are included. The incidence of any ROP, severe ROP and treatment modalities will be determined. The risk factors for ROP development will also be evaluated.
CONDITIONS
Official Title
Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants with birth weight over 1500 grams or gestational age 33 weeks or less who are considered at risk for retinopathy of prematurity and have been screened for ROP.
You will not qualify if you...
- Neonates who died before their first retinopathy of prematurity examination.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Baskent University
Ankara, Turkey (Türkiye)
Actively Recruiting
Research Team
S
Sezin Unal
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here